Isonics Decides To Sell Life Sciences Division

Isonics Corp. said Monday it will sell its life sciences division. The Golden company also said it would complete a 1 for 4 reverse stock split as part of a plan to keep its listing on Nasdaq.

MORE ON THIS TOPIC